A Phase 1, Randomized, Open Label, Crossover Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 06 Jan 2015
Price : $35 *
At a glance
- Drugs Deferitazole (Primary) ; Midazolam
- Indications Iron overload
- Focus Pharmacokinetics
- Sponsors Shire
- 08 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 26 Nov 2013 New trial record
- 01 Nov 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.